Marc Hermelin - the ousted head of KV Pharmaceutical Co. - and other key shareholders inched closer to implementing their proposed changes to the bylaws of the Brentwood-based drug maker.

On Wednesday, KV announced it had set Sept. 11 as the record date…

The shares of Brentwood-based KV Pharmaceutical have risen so sharply since June 9 that the New York Stock Exchange has contacted the troubled firm about the unusual trading activity.

It’s unclear what’s causing the steep increase and the company has a policy about not commenting…

There are big happenings at KV Pharmaceutical, the Brentwood-based drug company. On Tuesday, the company said it is expanding its nationwide voluntary recall to include its prescription prenatal vitamin and iron supplement products. They range from Chromagen iron supplement caplets to NutriNate…

KV Pharmaceutical Co., based in Brentwood, said Friday it estimated net sales of $163.6 million in the fiscal third quarter ended Dec. 31, up 38.7 percent from the prior year.

The company did not release net earnings figures. Its results are…